Stopping randomized trials early for benefit and estimation of treatment effects : systematic review and meta-regression analysis
Date Issued
2010-01-01
Author(s)
Bassler, Dirk
Montori, Victor M
Lane, Melanie
Glasziou, Paul
Zhou, Qi
Heels-Ansdell, Diane
Walter, Stephen D
Guyatt, Gordon H
STOPIT-2, Study Group
Flynn, David N
Elamin, Mohamed B
Murad, Mohammad Hassan
Abu Elnour, Nisrin O
Lampropulos, Julianna F
Sood, Amit
Mullan, Rebecca J
Erwin, Patricia J
Bankhead, Clare R
Perera, Rafael
Ruiz Culebro, Carolina
You, John J
Mulla, Sohail M
Kaur, Jagdeep
Nerenberg, Kara A
Schünemann, Holger
Cook, Deborah J
Lutz, Kristina
Ribic, Christine M
Vale, Noah
Malaga, German
Akl, Elie A
Ferreira-Gonzalez, Ignacio
Alonso-Coello, Pablo
Urrutia, Gerard
Raatz, Heike
da Silva, Suzana Alves
Tuche, Fabio
Strahm, Brigitte
Djulbegovic, Benjamin
Adhikari, Neill K J
Mills, Edward J
Gwadry-Sridhar, Femida
Kirpalani, Haresh
Soares, Heloisa P
Karanicolas, Paul J
Burns, Karen E A
Vandvik, Per Olav
Coto-Yglesias, Fernando
Chrispim, Pedro Paulo M
Ramsay, Tim
DOI
10.1001/jama.2010.310
Abstract
Theory and simulation suggest that randomized controlled trials (RCTs) stopped early for benefit (truncated RCTs) systematically overestimate treatment effects for the outcome that precipitated early stopping.